Ingen Technologies (OTCMKTS:IGNT) vs. Brainsway (NASDAQ:BWAY) Head-To-Head Comparison

Ingen Technologies (OTCMKTS:IGNT) and Brainsway (NASDAQ:BWAY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Insider and Institutional Ownership

30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Ingen Technologies has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Ingen Technologies and Brainsway, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingen Technologies	0	0	0	0	0.00
Brainsway	0	1	2	0	2.67

Brainsway has a consensus price target of $23.50, indicating a potential upside of 31.65%. Given Brainsway’s stronger consensus rating and higher probable upside, analysts clearly believe Brainsway is more favorable than Ingen Technologies.

Profitability

This table compares Ingen Technologies and Brainsway’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ingen Technologies	N/A	N/A	N/A
Brainsway	12.73%	9.46%	5.96%

Valuation and Earnings

This table compares Ingen Technologies and Brainsway”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingen Technologies	N/A	N/A	N/A	N/A	N/A
Brainsway	$49.09 million	7.11	$2.92 million	$0.30	59.50

Brainsway has higher revenue and earnings than Ingen Technologies.

Summary

Brainsway beats Ingen Technologies on 10 of the 10 factors compared between the two stocks.

About Ingen Technologies

Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States. It offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark names for patients suffering with chronic obstructive pulmonary disease. The company was founded in 1999 and is based in Riverside, California.

About Brainsway

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.